Literature DB >> 35224427

Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns.

Ali E Dabiri1,2, Ghassan S Kassab1.   

Abstract

Cannabis is currently the most consumed illicit substance in the world, and gradual legalization in the USA makes it important to understand the health consequences of the use of this substance. With growing body of evidence that some cannabis ingredients may be beneficial in various aspects of hemostasis, additional research is clearly needed in various clinical areas. In addition to understanding the efficacy, research efforts should also include studies that address any harmful effects of the compounds or administration methods that may result in adverse effects. This review is focused on the cardiometabolic effects of cannabis use. Cardiometabolic diseases are among the leading causes of death in the USA and around the world. The purpose of this review was to provide an overview of the known medicinal benefits of selected cannabis cannabinoids and the known side effects or contraindications. More importantly, we have proposed new questions and signposts in cannabis research to uncover additional medicinal benefits and identify the health hazards with focus on cardiovascular disease.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Illicit substance; Marijuana; Smoking; Synthetic cannabinoids

Year:  2021        PMID: 35224427      PMCID: PMC8832198          DOI: 10.1159/000519775

Source DB:  PubMed          Journal:  Med Cannabis Cannabinoids        ISSN: 2504-3889


  59 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

2.  Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.

Authors:  Sandra Blasco-Benito; Marta Seijo-Vila; Miriam Caro-Villalobos; Isabel Tundidor; Clara Andradas; Elena García-Taboada; Jeff Wade; Stewart Smith; Manuel Guzmán; Eduardo Pérez-Gómez; Mara Gordon; Cristina Sánchez
Journal:  Biochem Pharmacol       Date:  2018-06-27       Impact factor: 5.858

Review 3.  Cannabidiol as potential anticancer drug.

Authors:  Paola Massi; Marta Solinas; Valentina Cinquina; Daniela Parolaro
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 4.  Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?

Authors:  Arash Aryana; Mark A Williams
Journal:  Int J Cardiol       Date:  2006-09-26       Impact factor: 4.164

Review 5.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

Review 6.  Cannabinoid receptors: where they are and what they do.

Authors:  K Mackie
Journal:  J Neuroendocrinol       Date:  2008-05       Impact factor: 3.627

7.  Pulmonary function and cardiovascular risk factor relationships in black and in white young men and women. The CARDIA Study.

Authors:  M Higgins; J B Keller; L E Wagenknecht; M C Townsend; D Sparrow; D R Jacobs; G Hughes
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

Review 8.  Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Authors:  Yasmin L Hurd; Michelle Yoon; Alex F Manini; Stephanie Hernandez; Ruben Olmedo; Maria Ostman; Didier Jutras-Aswad
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 9.  Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature.

Authors:  Daniela Marchetti; Angelico Spagnolo; Valentino De Matteis; Laura Filograna; Nadia De Giovanni
Journal:  Drug Test Anal       Date:  2015-11-25       Impact factor: 3.345

10.  One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function.

Authors:  Xiaoyin Wang; Ronak Derakhshandeh; Jiangtao Liu; Shilpa Narayan; Pooneh Nabavizadeh; Stephenie Le; Olivia M Danforth; Kranthi Pinnamaneni; Hilda J Rodriguez; Emmy Luu; Richard E Sievers; Suzaynn F Schick; Stanton A Glantz; Matthew L Springer
Journal:  J Am Heart Assoc       Date:  2016-07-27       Impact factor: 5.501

View more
  1 in total

Review 1.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.